Financial & Tax Architects LLC Buys Shares of 868 UnitedHealth Group Incorporated (NYSE:UNH)

Financial & Tax Architects LLC bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 868 shares of the healthcare conglomerate’s stock, valued at approximately $442,000.

A number of other hedge funds have also added to or reduced their stakes in UNH. Macroview Investment Management LLC increased its stake in shares of UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after purchasing an additional 47 shares in the last quarter. True Wealth Design LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter worth $31,000. Delos Wealth Advisors LLC increased its stake in shares of UnitedHealth Group by 757.1% in the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 53 shares in the last quarter. Bbjs Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group in the 2nd quarter worth $31,000. Finally, Signature Resources Capital Management LLC increased its stake in shares of UnitedHealth Group by 40.0% in the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 18 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of brokerages have issued reports on UNH. Baird R W upgraded UnitedHealth Group to a “strong-buy” rating in a research note on Thursday, May 30th. Argus increased their price objective on shares of UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Tuesday. TD Cowen increased their price objective on shares of UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Finally, UBS Group increased their price objective on shares of UnitedHealth Group from $640.00 to $680.00 and gave the company a “buy” rating in a report on Thursday, July 18th. One investment analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Buy” and a consensus target price of $614.17.

Check Out Our Latest Stock Report on UNH

Insider Buying and Selling

In related news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction that occurred on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH opened at $577.89 on Wednesday. The firm has a market cap of $531.88 billion, a PE ratio of 35.32, a price-to-earnings-growth ratio of 1.64 and a beta of 0.58. The firm’s 50 day simple moving average is $572.79 and its 200-day simple moving average is $519.00. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $607.94. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. The business had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same period last year, the company posted $6.14 earnings per share. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Investors of record on Monday, September 16th will be paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.45%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is 51.34%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.